Skip to content
The Policy VaultThe Policy Vault

Noxafil (posaconazole delayed-release tablets [generic], oral suspension [generic], PowderMix for delayed-release oral suspension - Merck)Cigna

Fungal Infection (Systemic) in a Patient with Graft-versus-Host Disease – Prophylaxis

Initial criteria

  • Patient has graft-versus-host disease
  • Requires prophylaxis for systemic fungal infection

Approval duration

6 months